A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
Clinics of Surgery
1.1. Aims: Thymidine Kinase 1(TK1) is a precision protein molecular target for assessment of tumor proliferating rate. This investigation of 3 cases is whether the elevated STK1p after the 2-cycle -chemotherapy is associated with failure poor survival of clinical stage I-II in Non-Small-Cell Lung Carcinomas (NSCLCs). Main Methods: The 3 post-operative NSCLCs with clinical stage I-II were confirmed by pathology and followed by individual chemotherapy. The Serum Thymidine Kinase 1 protein (STK1p)doi:10.47829/cos.2021.61002 fatcat:z4cytm6atvhbpndlziu6jze5f4